HIMS
Hims & Hers Health, Inc.
NYSE · Healthcare · Medical - Equipment & Services · US
$27.55
−0.97%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.6B | 2.3B | 1.5B | 872.0M | 526.9M |
| Cost of Revenue | 910.5M | 614.3M | 303.4M | 157.1M | 118.2M |
| Gross Profit | 1.7B | 1.7B | 1.2B | 714.9M | 408.7M |
| Operating Expenses | |||||
| R&D Expense | 128.5M | 149.3M | 78.8M | 48.2M | 29.2M |
| SG&A Expense | 1.4B | 1.2B | 846.6M | 576.3M | 370.8M |
| General & Admin Expense | 431.9M | 272.7M | 167.8M | 129.9M | 98.2M |
| Selling & Marketing Expense | 954.4M | 919.3M | 678.8M | 446.4M | 272.6M |
| Other Expenses | 245.4M | 286.4M | 185.8M | 119.9M | 77.4M |
| Total Operating Expenses | 1.8B | 1.6B | 1.1B | 744.4M | 477.4M |
| Cost and Expenses | 2.7B | 2.2B | 1.4B | 901.5M | 595.6M |
| Operating Income (EBIT) | (92.7M) | 105.6M | 61.9M | (29.5M) | (68.7M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | (70.9M) | 18.3M | 9.8M | 7.9M | 3.0M |
| Non-Operating Income (excl Interest) | 70.9M | (18.3M) | (9.8M) | (7.9M) | (3.0M) |
| EBT (Pre-Tax Income) | (163.6M) | 123.9M | 71.7M | (21.6M) | (65.7M) |
| Income Tax Expense | (21.6M) | (4.4M) | (54.3M) | 2.0M | (31.0K) |
| Bottom Line | |||||
| Net Income | (142.0M) | 128.4M | 126.0M | (23.5M) | (65.7M) |
| Earnings from Cont. Ops | (142.0M) | 128.4M | 126.0M | (23.5M) | (65.7M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (142.0M) | 128.4M | 126.0M | (23.5M) | (65.7M) |
| Per Share | |||||
| Basic EPS | ($0.61) | $0.57 | $0.58 | ($0.11) | ($0.32) |
| Diluted EPS | ($0.63) | $0.51 | $0.53 | ($0.11) | ($0.32) |
| Revenue Per Share | $11.12 | $10.44 | $6.84 | $4.17 | $2.58 |
| Shares | |||||
| Basic Shares Outstanding | 231.7M | 225.0M | 215.9M | 209.3M | 204.5M |
| Diluted Shares Outstanding | 231.7M | 258.2M | 236.8M | 209.3M | 204.5M |
| Profitability Metrics | |||||
| EBITDA | (76.4M) | 178.4M | 88.8M | (12.1M) | (58.2M) |
| D&A | 87.2M | 54.5M | 17.1M | 9.5M | 7.5M |
| EBIT | (163.6M) | 123.9M | 71.7M | (21.6M) | (65.7M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026